Are we getting closer to valid translational models for major depression?

Science

Volumn 338, Issue 6103, 2012, Pages 75-79

  Berton, Olivier ^a   Hahn, Chang Gyu ^a   Thase, Michael E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN;

DISEASE TREATMENT; ETHICS; MEDICINE; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; NEUROLOGY; NUMERICAL MODEL; PATHOLOGY; RESEARCH WORK; SYMPTOM; TECHNOLOGICAL DEVELOPMENT;

AFFECT; ANHEDONIA; AVERSION; BRAIN DEPTH STIMULATION; COGNITION; DYSPHORIA; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HABENULA; HUMAN; LIMBIC CORTEX; MAJOR DEPRESSION; MONOAMINERGIC SYSTEM; MOTIVATION; NEGLECT; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PANIC; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SEROTONINERGIC NERVE CELL; SOCIAL STRESS; STRESS; VIOLENCE;

EID: 84867217874     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1222940     Document Type: Review

References (61)

1. M. E. Thase, in Handbook of Depression, I. H. Gotlib and C. L. Hammen, Eds. (Guilford Press, New York, 2008), pp. 187-216.
2. R. Bogdan, Y. S. Nikolova, D. A. Pizzagalli, Neurobiol. Dis. (2012).
3. J. W. Buckholtz, A. Meyer-Lindenberg, Neuron 74, 990 (2012).
4. G. Griebel, F. Holsboer, Nat. Rev. Drug Discov. 11, 462 (2012).
5. E. J. Nestler, S. E. Hyman, Nat. Neurosci. 13, 1161 (2010).
6. L. L. Zeng et al., Brain 135, 1498 (2012).
7. T. Hahn et al., Arch. Gen. Psychiatry 68, 361 (2011).
8. J. K. Cohn et al., presentation at the Third Conference on Affective Computing and Intelligent Interaction and Workshops, 2009 (ACII 2009), 10 to 12 September 2009 (IEEE, Piscataway, NJ, 2010).
9. X. Zhang, Z. S. Yaseen, I. I. Galynker II, J. Hirsch, A. Winston, PLoS ONE 6, e27253 (2011).
10. M. K. Lobo, E. J. Nestler, H. E. Covington 3rd, Biol. Psychiatry 71, 1068 (2012).
11. K. Dzirasa, R. Fuentes, S. Kumar, J. M. Potes, M. A. Nicolelis, J. Neurosci. Methods 195, 36 (2011).
12. D. Refojo et al., Science 333, 1903 (2011).
13. R. D. Airan et al., Science 317, 819 (2007).
14. A. E. Autry et al., Nature 475, 91 (2011).
15. C. Hamani, J. N. Nóbrega, Eur. J. Neurosci. 32, 1109 (2010).
16. M. R. Warden et al., presentation no. 306.15/YY26, 2011 Neuroscience Meeting Planner (Society for Neuroscience, Washington, DC, 2011).
17. S. J. Shabel, C. D. Proulx, A. Trias, R. T. Murphy, R. Malinow, Neuron 74, 475 (2012).
18. B. Li et al., Nature 470, 535 (2011).
19. A. Der-Avakian, A. Markou, Trends Neurosci. 35, 68 (2012).
20. B. K. Lim, K. W. Huang, B. A. Grueter, P. E. Rothwell, R. C. Malenka, Nature 487, 183 (2012).
21. J. L. Warner-Schmidt et al., Proc. Natl. Acad. Sci. U.S.A. 109, 11360 (2012).
22. A. M. Cusi, A. Nazarov, K. Holshausen, G. M. Macqueen, M. C. McKinnon, J. Psychiatry Neurosci. 37, 154 (2012).
23. H. R. Ferdowsian et al., PLoS ONE 6, e19855 (2011).
24. C. A. Shively, S. L. Willard, Exp. Neurol. 233, 87 (2012).
25. T. D. Perera et al., PLoS ONE 6, e17600 (2011).
26. O. Berton et al., Science 311, 864 (2006).
27. E. Malatynska, R. Rapp, D. Harrawood, G. Tunicliff, Pharmacol. Biochem. Behav. 82, 306 (2005).
28. J. L. Cao et al., J. Neurosci. 30, 16453 (2010).
29. D. J. Christoffel et al., J. Neurosci. 31, 314 (2011).
30. J. Espallergues et al., J. Neurosci. 32, 4400 (2012).
31. V. Narayanan et al., PLoS ONE 6, e22600 (2011).
32. H. E. Covington 3rd et al., J. Neurosci. 30, 16082 (2010).
33. F. Wang et al., Science 334, 693 (2011).
34. S. G. Disner, C. G. Beevers, E. A. Haigh, A. T. Beck, Nat. Rev. Neurosci. 12, 467 (2011).
35. K. Amemori, A. M. Graybiel, Nat. Neurosci. 15, 776 (2012).
36. E. J. Harding, E. S. Paul, M. Mendl, Nature 427, 312 (2004).
37. S. H. Richter et al., Cogn. Affect. Behav. Neurosci. 12, 527 (2012).
38. S. Dong, S. C. Rogan, B. L. Roth, Nat. Protoc. 5, 561 (2010).
39. L. H. Tecott, E. J. Nestler, Nat. Neurosci. 7, 462 (2004).
40. D. Kokel et al., Nat. Chem. Biol. 6, 231 (2010).
41. L. Ziv et al., Mol. Psychiatry (2012).
42. H. Yu et al., J. Neurosci. 32, 4092 (2012).
43. J. M. Beaulieu et al., Proc. Natl. Acad. Sci. U.S.A. 105, 1333 (2008).
44. A. M. Carneiro et al., Proc. Natl. Acad. Sci. U.S.A. 106, 2047 (2009).
45. Y. Furukawa-Hibi et al., Neuroreport 21, 1177 (2010).
46. A. R. Hariri, Sci. Transl. Med. 2, 18ps6 (2010).
47. F. Soliman et al., Science 327, 863 (2010).
48. M. A. Kohli et al., Neuron 70, 252 (2011).
49. J. J. Rucker et al., Mol. Psychiatry (2011).
50. J. T. Glessner et al., PLoS ONE 5, e15463 (2010).
51. D. J. Porteous, J. K. Millar, N. J. Brandon, A. Sawa, Trends Mol. Med. 17, 699 (2011).
52. P. A. Thomson et al., Mol. Psychiatry (2012).
53. C. H. Chiang et al., Mol. Psychiatry 16, 358 (2011).
54. K. E. Borgmann-Winter et al., Neuroscience 158, 642 (2009).
55. H. J. Kang et al., Nat. Med. 18, 1413 (2012).
56. V. Krishnan, E. J. Nestler, Am. J. Psychiatry 167, 1305 (2010).
57. E. S. Deneris, S. C. Wyler, Nat. Neurosci. 15, 519 (2012).
58. E. F. Schmidt et al., Cell 149, 1152 (2012).
59. H. Sun, P. J. Kennedy, E. J. Nestler, Neuropsychopharmacology (2012).
60. W. T. McKinney Jr., S. J. Suomi, H. F. Harlow, Am. J. Psychiatry 127, 1313 (1971).
61. S. L. Willard, J. B. Daunais, J. M. Cline, C. A. Shively, Menopause 18, 582 (2011).